MedTrace Logo

Study of Efficacy, Pharmacokinetics and Safety of Continuous Intravenous Infusion of Org 9426 (Study P05977)

NCT00988520 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2015-05-12

No results posted yet for this study

Summary

The purpose of this study is to compare the infusion rate of Org 9426 following intubating dose of Org 9426 0.6 mg/kg or 0.9 mg/kg in adult surgical patients.

Conditions

  • Anesthesia

Interventions

DRUG

Rocuronium bromide

Continuous intravenous infusion initiated at 7 μg/kg/min and adjusted to maintain muscle relaxation

DRUG

Rocuronium bromide

Intubation dose of 0.6 mg/kg injection

DRUG

Rocuronium bromide

Intubation dose of 0.9 mg/kg injection

DRUG

Sevoflurane

0.5-2.0% intravenous maintenance anesthesia

DRUG

Propofol

4010 mg/kg/hr intravenous maintenance anesthesia

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2003-09-30
Completion
2003-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00988520 on ClinicalTrials.gov